Email
Password
Remember meForgot password?
    Log in with Twitter
Blog In Health

FDA issue list of products with safety label changes

blog:16150:1::0
By Tim Sandle
Posted Apr 13, 2012 in Health
The US Food and Drug Administration (FDA) has issued a list of medicines which have received safety lable changes over the past four weeks.
Further details can be found at [url=http://: http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm299284.htm? t=_blank]FDA Medwatch.
Here is the list:
Atacand HCT (candesartan cilextetil/hydrochlorothiazide)
Benicar (olmesartan medoxomil)
Sporanox (itraconazole)
Twynsta (telmisartan/amlodipine)
Zestoretic (lisinopril/hydrochlorothiazide)
Zestril (lisinopril)
Benlysta (belimumab)
Celexa (citalopram hydrobromide)
Enablex (darifenacin)
Incivek (telaprevir)
Janumet (sitagliptin and metformin fixed-dose combination)
Januvia (sitagliptin)
Kombiglyze XR (saxagliptin/metformin hydrochloride extended-release)
Lidocaine in 5% Dextrose Injection
Magnevist (brand of gadopentetate dimeglumine)
Revlimid (lenalidomide)
Reyataz (atazanavir sulfate)
Treximet (sumatriptan and naproxen sodium)
Votrient (pazopanib)
Zometa (zoledronic acid)
Zmax (azithromycin extended release)

blog:16150:1::0
More about Fda, Medicine
Latest News
Top News